Pioneering change: how pharmacogenomics is shaping healthcare

"There's increasing evidence and recognition of the economic benefits of genetic testing - reducing the consequences stemming from adverse drug reactions while optimizing (and even reducing) total prescriptions written."

Few healthcare verticals positively impact the Triple Aim - improving the patient/provider experience, reducing costs, and influencing outcomes.

Click here to read the full article.